Vical Incorporated (NASDAQ: VICL)

Vical Incorporated (NASDAQ: VICL) is focused on researching and developing biopharmaceutical products designed to prevent and treat serious or life-threatening diseases. Possible applications of the company’s DNA delivery technology include DNA vaccines for infectious diseases or cancer, cancer immunotherapeutics, and cardiovascular therapies. By strategically partnering with other pharmaceutical companies and biotechnology companies, the company hopes to expand its product pipeline. For further information, visit the Company’s web site at www.vical.com.